Search Within

Christopher Antonio Febres Aldana

Formats
  1. Meeting Abstract (15)
  2. Journal Article (11)
  3. Review (2)
  4. Editorial (1)
Groups
  1. GME, Pathology (29)
  2. Graduate Medical Education (29)
  3. Department of Pathology and Laboratory Medicine (28)
  4. Department of Medicine (21)
  5. GSK Faculty (21)
  6. Solid Tumor Oncology Division (21)

More Groups

People
  1. Marc Ladanyi (18)
  2. Natasha Rekhtman (18)
  3. Jason Chang (15)
  4. William Travis (14)
  5. Francis Bodd (9)
  6. Soo Ryum Yang (9)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (4)
  4. 2022 (9)
  5. 2021 (2)
Publications
  1. Modern Pathology (7)
  2. Laboratory Investigation (6)
  3. Journal of Thoracic Oncology (4)
  4. Clinical Cancer Research (3)
  5. Cancer Discovery (2)
  6. Annual Review of Pathology: Mechanisms of Disease (1)

More Publications

Publishers
  1. Nature Publishing Group (8)
  2. Nature Research (7)
  3. American Association for Cancer Research (5)
  4. Elsevier Inc. (4)
  5. American Society of Clinical Oncology (1)
  6. Annual Reviews (1)

More Publishers

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma
    Journal Article

    Shi, R.; Farnsworth, D. A.; Febres-Aldana, C. A.; Chow, J. L. M.; Sheena, R.; Atwal, T.; Gomez Marti, J. L.; Li, S.; Thomas, K. N.; Lee, C. M.; more...
    Oncogene (2025)

    Fulltext@MSK | Save
  • Pan-cancer analysis of oncogenic MET fusions reveals distinct pathogenomic subsets with differential sensitivity to MET-targeted therapy
    Journal Article

    Febres-Aldana, C. A.; Vojnic, M.; Odintsov, I.; Zhang, T.; Cheng, R.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A. M.; Gili, L.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Integrin-linked kinase drives drug-tolerant persister cell survival and EMT in response to EGFR inhibition in lung adenocarcinoma
    Meeting Abstract

    Shi, R.; Farnsworth, D. A.; Febres-Aldana, C. A.; Chow, J. L. M.; Sheena, R.; Atwal, T.; Marti, J. L. G.; Thomas, K. N.; Lee, C. M.; Awrey, S. J.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Chromothripsis-mediated small cell lung carcinoma
    Journal Article

    Rekhtman, N.; Tischfield, S. E.; Febres-Aldana, C. A.; Lee, J. J. K.; Chang, J. C.; Herzberg, B. O.; Selenica, P.; Woo, H. J.; Vanderbilt, C. M.; Yang, S. R.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Analysis of ASCL1/NEUROD1/POU2F3/YAP1 yields novel insights for the diagnosis of olfactory neuroblastoma and identifies sinonasal tuft cell–like carcinoma
    Journal Article

    Febres-Aldana, C. A.; Elsayad, M. M.; Saliba, M.; Bhanot, U.; Ntiamoah, P.; Takeyama, A.; Purgina, B. M.; Rodriguez-Urrego, P. A.; Marusic, Z.; Jakovcevic, A.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • RRAS and RRAS2 mutations are oncogenic drivers in lung cancer and are sensitive to the PAN-RAS inhibitor RMC-6236
    Meeting Abstract

    Pfeil, A. J.; Zhang, T.; Febres-Aldana, C. A.; Cheng, R.; Mattar, M. S.; Arbour, K.; Ladanyi, M.; Yang, S. R.; Somwar, R.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Comprehensive pan-cancer analysis of oncogenic MET rearrangements with a focus on targetability in NSCLC
    Meeting Abstract

    Vojnic, M.; Febres-Aldana, C. A.; Odintsov, I.; Zhang, T.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A.; Gili, L.; Harshan, M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Comprehensive pan-cancer analysis of oncogenic ERBB2 fusions
    Meeting Abstract

    Gomez Marti, J.; Zhang, T.; Febres Aldana, C.; Cheng, R.; Mattar, M.; Gili, L.; Master, R.; Liu, Z.; Ladanyi, M.; Somwar, R.
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Cellular ATP demand creates metabolically distinct subpopulations of mitochondria
    Journal Article

    Ryu, K. W.; Fung, T. S.; Baker, D. C.; Saoi, M.; Park, J.; Febres-Aldana, C. A.; Aly, R. G.; Cui, R.; Sharma, A.; Fu, Y.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • HER2 antibody-drug conjugates are active against desmoplastic small round cell tumor
    Journal Article

    Zhang, T.; Febres-Aldana, C. A.; Liu, Z.; Dix, J. M.; Cheng, R.; Dematteo, R. G.; Lui, A. J. W.; Khodos, I.; Gili, L.; Mattar, M. S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save